Do Hip Injections Improve Short-Term Biomechanical Outcomes In Patients With Hip Pain

NCT01390103 | Completed

• 1 other identifier: 711-2010
• Study Type: observational
• Target: 29
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this project is to determine the effect of hip injections on hip biomechanics in patients with hip pain.

Conditions

Hip Pain

Keywords

hip pain

Outcome Measures

Primary Outcomes (1)

• Determine the immediate biomechanical effect in patients that receive a hip injection.

  The biomechanical assessment of gait will consist of walking on a gait mat. The mat is a specialized pressure sensor system. Prior to data collection, each participant will walk across the mat three times for acclimation. The first assessment will include a walk at a self-selected, comfortable pace across the mat, repeated three times. The second assessment will include walking as quickly as possible, also repeated three times.

  The short-term biomechanical effects of the hip will be evaluated within 1 hour of the patient receiving the injection.

Secondary Outcomes (4)

• Oswestry Hip Pain Disability Questionnaire

  Baseline, Within 1 hour of hip injection, 2 weeks post-injection

• Medical Outcomes Study (MOS) Short-Form Health Survey (SF-12)

  Baseline, Within 1 hour of injection, 2 weeks post-injection

• 10 centimeter Visual Analog Scale (VAS)

  Baseline, Within 1 hour of injection, 2 weeks post-injection

• Pain Provocative Maneuvers

  Baseline, Within 1 hour of injection, 2 weeks pos-injection

Study Arms (1)

Assessment following the hip injection

Assessment to evaluate the effect of the hip injection on biomechanics.

Other: Assessment following hip injection

Interventions

Assessment following hip injection OTHER

Assessment to evaluate the effect of the hip injection on biomechanics.

Assessment following the hip injection

Eligibility Criteria

• Age: 18 Years - 90 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Potential subjects will be all patients receiving a hip injection for hip pain.

You may qualify if:

• Osteoarthritis patients with hip pain requiring hip injection
• Receiving hip injection
• BMI \< 35

You may not qualify if:

• BMI \> 35
• severely impaired intellectual capacity
• dementia, or other neurodegenerative diseases that would preclude appropriate cognitive or physical ability to perform study protocol

Sponsors & Collaborators

• University of Florida: lead

Study Sites (1)

UF&Shands Orthopaedics and Sports Medicine Institute

Gainesville, Florida, 32607, United States

Location

Study Officials

• MaryBeth Horodyski, PhD

  University of Florida Departmen of Orthopaedics

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 5, 2011
• First Posted: July 8, 2011
• Study Start: March 1, 2011
• Primary Completion: October 1, 2012
• Study Completion: October 1, 2012
• Last Updated: April 22, 2013

Record last verified: 2013-04

Locations

US (1)